End-of-day quote
Thailand S.E.
23:00:00 16/05/2024 BST
|
5-day change
|
1st Jan Change
|
2.6
THB
|
+1.56%
|
|
-4.41%
|
+13.04%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,367
|
1,647
|
1,091
|
Enterprise Value (EV)
1 |
2,900
|
1,502
|
1,361
|
P/E ratio
|
89.8
x
|
-90.5
x
|
-851
x
|
Yield
|
0.18%
|
-
|
-
|
Capitalization / Revenue
|
7.85
x
|
3.77
x
|
1.84
x
|
EV / Revenue
|
6.76
x
|
3.44
x
|
2.29
x
|
EV / EBITDA
|
46.4
x
|
748
x
|
39.9
x
|
EV / FCF
|
-565
x
|
-4.96
x
|
-8.02
x
|
FCF Yield
|
-0.18%
|
-20.2%
|
-12.5%
|
Price to Book
|
3.48
x
|
1.75
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
455,000
|
455,000
|
474,555
|
Reference price
2 |
7.400
|
3.620
|
2.300
|
Announcement Date
|
28/02/22
|
28/02/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
352.2
|
369.3
|
462.7
|
429.1
|
436.5
|
594.4
|
EBITDA
1 |
43.31
|
58.53
|
68.99
|
62.42
|
2.008
|
34.1
|
EBIT
1 |
30.21
|
42.93
|
53.12
|
47.83
|
-15.06
|
0.6583
|
Operating Margin
|
8.58%
|
11.62%
|
11.48%
|
11.15%
|
-3.45%
|
0.11%
|
Earnings before Tax (EBT)
1 |
16.87
|
30.09
|
39.68
|
37.43
|
-21.44
|
6.51
|
Net income
1 |
12.39
|
23.57
|
31.08
|
29.69
|
-17.48
|
-1.269
|
Net margin
|
3.52%
|
6.38%
|
6.72%
|
6.92%
|
-4.01%
|
-0.21%
|
EPS
2 |
0.0562
|
0.0816
|
0.0927
|
0.0824
|
-0.0400
|
-0.002704
|
Free Cash Flow
1 |
-53.18
|
1.769
|
16.22
|
-5.13
|
-302.6
|
-169.8
|
FCF margin
|
-15.1%
|
0.48%
|
3.5%
|
-1.2%
|
-69.33%
|
-28.57%
|
FCF Conversion (EBITDA)
|
-
|
3.02%
|
23.51%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
7.51%
|
52.18%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.0132
|
-
|
-
|
Announcement Date
|
23/04/21
|
23/04/21
|
23/04/21
|
28/02/22
|
28/02/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
238
|
198
|
209
|
-
|
-
|
270
|
Net Cash position
1 |
-
|
-
|
-
|
467
|
146
|
-
|
Leverage (Debt/EBITDA)
|
5.493
x
|
3.384
x
|
3.03
x
|
-
|
-
|
7.914
x
|
Free Cash Flow
1 |
-53.2
|
1.77
|
16.2
|
-5.13
|
-303
|
-170
|
ROE (net income / shareholders' equity)
|
13.6%
|
17.1%
|
17.2%
|
5.11%
|
-1.83%
|
-0.28%
|
ROA (Net income/ Total Assets)
|
4.6%
|
6.11%
|
7.17%
|
3.43%
|
-0.76%
|
0.03%
|
Assets
1 |
269.4
|
385.5
|
433.5
|
866.4
|
2,307
|
-4,174
|
Book Value Per Share
2 |
0.4300
|
0.5200
|
0.5800
|
2.120
|
2.070
|
1.830
|
Cash Flow per Share
2 |
0
|
0
|
0
|
1.370
|
0.2100
|
0.0400
|
Capex
1 |
52.2
|
17
|
7.15
|
36.5
|
289
|
173
|
Capex / Sales
|
14.82%
|
4.6%
|
1.54%
|
8.52%
|
66.11%
|
29.09%
|
Announcement Date
|
23/04/21
|
23/04/21
|
23/04/21
|
28/02/22
|
28/02/23
|
29/02/24
|
|
1st Jan change
|
Capi.
|
---|
| +13.04% | 34.16M | | +32.09% | 693B | | +29.39% | 584B | | -1.34% | 372B | | +20.34% | 332B | | +7.39% | 294B | | +14.25% | 239B | | -3.03% | 211B | | +10.02% | 210B | | +8.49% | 168B |
Other Pharmaceuticals
|